FIGURE
Fig. 1
- ID
- ZDB-FIG-240411-19
- Publication
- Liu et al., 2024 - Targeting CD38/cyclic ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment
- Other Figures
- All Figure Page
- Back to All Figure Page
Fig. 1
Model construction of virtual screening and discovery of candidate compounds. (A) Prediction score of 41 compounds of Sanguisorba officinalis L. binding with the ADP ribosyl cyclase structure of CD38. (B) Molecular docking simulation reveals the interaction between compounds (ZGSⅡ, DMA, CG, PB3, OA, BA) and the ADP ribosyl cyclase structure of CD38. (C-H) The RMSD and RMSF values were obtained for the ADP ribosyl cyclase structure complexed with ZGSⅡ, DMA, CG, PB3, OA, and BA, respectively. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Pharmacol. Res.